AU2018342449A1 - Devices, systems and methods for biomarker analysis - Google Patents

Devices, systems and methods for biomarker analysis Download PDF

Info

Publication number
AU2018342449A1
AU2018342449A1 AU2018342449A AU2018342449A AU2018342449A1 AU 2018342449 A1 AU2018342449 A1 AU 2018342449A1 AU 2018342449 A AU2018342449 A AU 2018342449A AU 2018342449 A AU2018342449 A AU 2018342449A AU 2018342449 A1 AU2018342449 A1 AU 2018342449A1
Authority
AU
Australia
Prior art keywords
instances
sample
sequence
minutes
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018342449A
Other languages
English (en)
Inventor
Jim CHAUVAPUN
Mathias Ehrich
Paul OETH
Dirk Van Den Boom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Juno Diagnostics Inc
Original Assignee
Juno Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juno Diagnostics Inc filed Critical Juno Diagnostics Inc
Publication of AU2018342449A1 publication Critical patent/AU2018342449A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0681—Filter
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0825—Test strips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60—Detection means characterised by use of a special device
    • C12Q2565/625—Detection means characterised by use of a special device being a nucleic acid test strip device, e.g. dipsticks, strips, tapes, CD plates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Clinical Laboratory Science (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2018342449A 2017-09-26 2018-09-26 Devices, systems and methods for biomarker analysis Abandoned AU2018342449A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762563314P 2017-09-26 2017-09-26
US62/563,314 2017-09-26
US201762609086P 2017-12-21 2017-12-21
US62/609,086 2017-12-21
PCT/US2018/052891 WO2019067567A1 (en) 2017-09-26 2018-09-26 DEVICES, SYSTEMS AND METHODS FOR BIOMARKER ANALYSIS

Publications (1)

Publication Number Publication Date
AU2018342449A1 true AU2018342449A1 (en) 2020-04-16

Family

ID=65903224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018342449A Abandoned AU2018342449A1 (en) 2017-09-26 2018-09-26 Devices, systems and methods for biomarker analysis

Country Status (8)

Country Link
US (2) US20200263167A1 (enExample)
EP (1) EP3688158A4 (enExample)
JP (1) JP2020534873A (enExample)
KR (1) KR20200083461A (enExample)
CN (1) CN111406107A (enExample)
AU (1) AU2018342449A1 (enExample)
CA (1) CA3076809A1 (enExample)
WO (1) WO2019067567A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200299677A1 (en) 2017-10-27 2020-09-24 Juno Diagnostics, Inc. Devices, systems and methods for ultra-low volume liquid biopsy
EP3517957B1 (en) 2018-01-24 2019-12-18 Midge Medical GmbH Testing assembly and testing device for lateral flow assay
US12462935B2 (en) 2018-03-30 2025-11-04 Nucleix Ltd. Deep learning-based methods, devices, and systems for prenatal testing
US20220251650A1 (en) * 2019-09-23 2022-08-11 Gateway Genomics, Llc Methods, compositions, and kits for determining the sex of a fetus
CA3162239A1 (en) * 2019-11-27 2021-06-03 Juno Diagnostics, Inc. Systems and devices for sample preparation and analyte detection
DE102020109744A1 (de) * 2020-04-07 2021-10-07 Midge Medical Gmbh System und Vorrichtung zum Analysieren einer Probe
US20220042085A1 (en) * 2020-08-07 2022-02-10 Genalyze LLC System and method of nucleic acid amplification for point of collection
EP3967772A1 (en) * 2020-09-14 2022-03-16 Ducrest, Percevent Tools & methods usefool for detection of lactose intolerance and uses thereof
EP4263869A4 (en) * 2020-12-15 2025-01-08 Gateway Genomics, LLC METHODS, COMPOSITIONS AND DEVICES FOR THE RAPID DETERMINATION OF THE SEX OF A FETUS
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
CA3215385A1 (en) * 2021-04-14 2022-10-20 Namal NAWANA Self-contained dermal patch for detection of physiological analytes
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US11510602B1 (en) 2021-11-08 2022-11-29 Satio, Inc. Dermal patch for collecting a physiological sample
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
CA3220201A1 (en) * 2021-06-02 2022-12-08 Jose ZEVALLOS Systems and methods for multimodal analysis of surgical drain fluid using interchangeable and customizable nucleic acid based tests
US12152280B2 (en) 2021-09-20 2024-11-26 Droplet Biosciences, Inc. Drain fluid for diagnostics
CA3247873A1 (en) * 2022-01-28 2023-08-03 The Johns Hopkins University BIO-MODIFIED ENZYMES AND THEIR USES
CN221028439U (zh) * 2022-09-30 2024-05-28 台达电子国际（新加坡）私人有限公司 可携式核酸检测装置
US12435357B2 (en) 2022-12-22 2025-10-07 Kanso Diagnostics Ltd. Diagnostic device for detecting a target nucleic acid molecule in a biological sample

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1570043B1 (en) * 2002-12-12 2013-07-24 Novartis Vaccines and Diagnostics, Inc. Device and method for in-line blood testing using biochips
WO2004112602A1 (en) * 2003-06-13 2004-12-29 Pelikan Technologies, Inc. Method and apparatus for a point of care device
US20080102493A1 (en) * 2006-06-29 2008-05-01 Millipore Corporation Isolation of RNA and DNA from a biological sample
FR2923151B1 (fr) * 2007-11-02 2010-09-03 Commissariat Energie Atomique Dispositif de prelevement sanguin comportant au moins un filtre .
CA2717320A1 (en) * 2008-03-11 2009-09-17 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
EP2113574A1 (en) * 2008-04-28 2009-11-04 Biotype AG Substances and methods for a DNA based profiling assay
WO2011053790A2 (en) * 2009-10-30 2011-05-05 Fluidigm Corporation Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis
WO2011063324A2 (en) * 2009-11-20 2011-05-26 The General Hospital Corporation Microfluidic systems for isolating microvesicles
EP2516677B1 (en) * 2009-12-23 2014-11-26 Genetic Technologies Limited Methods of enriching and detecting fetal nucleic acids
EP2992827B1 (en) * 2010-11-09 2017-04-19 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
WO2012174256A2 (en) * 2011-06-17 2012-12-20 The Regents Of The University Of Michigan Dna methylation profiles in cancer
EP2676606B1 (en) * 2012-06-20 2017-05-03 Fabpulous B.V. Quick test device and method
US10262107B1 (en) * 2013-03-15 2019-04-16 Bao Tran Pharmacogenetic drug interaction management system
US9644232B2 (en) * 2013-07-26 2017-05-09 General Electric Company Method and device for collection and amplification of circulating nucleic acids
US10472620B2 (en) * 2014-07-01 2019-11-12 General Electric Company Method, substrate and device for separating nucleic acids
CA2991918A1 (en) * 2014-07-11 2016-01-14 Advanced Theranostics Inc. Point of care polymerase chain reaction device for disease detection
US10335078B2 (en) * 2014-08-04 2019-07-02 General Electric Company Device for separation and collection of plasma
US10913068B2 (en) * 2015-03-13 2021-02-09 Nanyang Technological University Testing device, microfluidic chip and nucleic acid testing method
WO2016188430A1 (en) * 2015-05-25 2016-12-01 Coyote Bioscience Co., Ltd. Devices and methods for sample collection cross-reference
ES2912965T3 (es) * 2015-09-09 2022-05-30 Drawbridge Health Inc Dispositivos para la recopilación, estabilización y conservación de muestras
PL3350342T3 (pl) * 2015-09-18 2020-08-24 Vanadis Diagnostics Zestaw sond do analizowania próbki DNA i sposób jego zastosowania
WO2017136430A1 (en) * 2016-02-01 2017-08-10 The Board Of Trustees Of The Leland Stanford Junior University Exosome-total-isoloation-chip (exotic) device for isolation of exosome-based biomarkers
KR102349487B1 (ko) * 2016-08-24 2022-01-10 벡톤 디킨슨 앤드 컴퍼니 혈액 샘플의 획득을 위한 장치
DK3336197T3 (da) * 2016-12-16 2022-07-11 Eurofins Genomics Europe Sequencing GmbH Epigenetiske markører og relaterede fremgangsmåder og midler til detektion og behandling af ovariekræft
CN106978486A (zh) * 2017-03-24 2017-07-25 刘长胜 无细胞dna作为癌症免疫药物疗效评价的分子靶标及其应用

Also Published As

Publication number Publication date
KR20200083461A (ko) 2020-07-08
US20200263167A1 (en) 2020-08-20
JP2020534873A (ja) 2020-12-03
US20220119801A1 (en) 2022-04-21
WO2019067567A1 (en) 2019-04-04
EP3688158A4 (en) 2021-06-16
CN111406107A (zh) 2020-07-10
EP3688158A1 (en) 2020-08-05
CA3076809A1 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
US20220119801A1 (en) Devices, systems and methods for biomarker analysis
US11525134B2 (en) Devices, systems and methods for ultra-low volume liquid biopsy
US20220162591A1 (en) Optimized ultra-low volume liquid biopsy methods, systems, and devices
US20220170915A1 (en) Digital health ecosystem
Board et al. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer
EP3724350A1 (en) A non-invasive method for monitoring transplanted organ status in organ-transplant recipients
Mestry et al. Key methodological challenges in detecting circulating miRNAs in different biofluids
Tungwiwat et al. Development and Application of a Real‐Time Quantitative PCR for Prenatal Detection of Fetal α0‐Thalassemia from Maternal Plasma
Pattar et al. Circulating nucleic acids as biomarkers for allograft injury after solid organ transplantation: current state-of-the-art
Uchiyama et al. Understanding quantitative polymerase chain reaction bioanalysis issues before validation planning: Japan Bioanalysis Forum discussion group
US20220404353A1 (en) Systems and devices for sample preparation and analyte detection
Liu et al. Primer-introduced restriction analysis polymerase chain reaction method for non-invasive prenatal testing of β-thalassemia
Maron et al. Comparative performance analyses of commercially available products for salivary collection and nucleic acid processing in the newborn
Alhur et al. Fetal nucleated red blood cells preferable than cell-free fetal DNA for early determination of gender among invasive and non-invasive source using novel four genes multiplex PCR
Weymaere et al. Enrichment of circulating trophoblasts from maternal blood using filtration-based Metacell® technology
Chadud et al. Assessment of free fetal DNA concentration in maternal plasma during the first trimester of pregnancy: comparative study between EDTA and PPT tubes–pilot study

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application